Editas Medicine Inc (EDIT)
1.31
-0.03
(-2.24%)
USD |
NASDAQ |
Dec 20, 16:00
1.33
+0.02
(+1.53%)
After-Hours: 20:00
Editas Medicine Profit Margin (Quarterly): -101.9K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | -105.0% |
| EyePoint Pharmaceuticals Inc | -279.0% |
| Cassava Sciences Inc | -- |
| Adverum Biotechnologies Inc | -2.71K% |
| Regenxbio Inc | -246.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -74.59% |
| Return on Assets | -48.82% |
| Return on Invested Capital | -74.59% |
| Operating Margin (Quarterly) | -107.6K% |
| Return on Net Operating Assets | -422.2% |